TickerFactsScreenerDevelopers

SELLAS Life Sciences Group, Inc. (SLS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$10.26M2011: -$14.67M2012: -$20.97M2013: -$28.93M2014: -$42.87M2015: -$48.16M2016: -$11.85M2017: -$10.99M2018: -$30.42M2019: -$17.64M2020: -$10.42M2021: -$26.02M2022: -$23.81M2023: -$31.41M2024: -$35.40M2025: -$28.39M-$28.39M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$28.39M+19.8%
2024-$35.40M-12.7%
2023-$31.41M-31.9%
2022-$23.81M+8.5%
2021-$26.02M-149.8%
2020-$10.42M+41.0%
2019-$17.64M+42.0%
2018-$30.42M-176.8%
2017-$10.99M+7.3%
2016-$11.85M+75.4%
2015-$48.16M-12.3%
2014-$42.87M-48.2%
2013-$28.93M-37.9%
2012-$20.97M-43.0%
2011-$14.67M-43.0%
2010-$10.26M—